Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

Slides:

Advertisements

Similar presentations

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,

Advertisements

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial Domenico Paparella, MD, Crescenzia.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Levosimendan Facilitates Weaning From Cardiopulmonary Bypass in Patients Undergoing Coronary Artery Bypass Grafting With Impaired Left Ventricular Function

Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration Jean-Olivier Defraigne, MD, PhD,

Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy Thomas Menzel, MD, Thorsten Kramm, MD, Stephan Wagner, MD, Susanne Mohr-Kahaly,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients Lena Lindholm,

P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J

Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

Prospective, Randomized, Double-Blind Study of High-Dose Aprotinin in Pediatric Cardiac Operations Michael J Davies, FRCS, Alison Allen, BScHons, Henry.

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Assessment of heparin anticoagulation: comparison of two commercially available methods Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,

Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass Yukio Chiba, Kouichi Morioka, Ryusuke Muraoka, Akio.

Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization Hiroshi Kumano, MD, PhD, Shigefumi Suehiro, MD, PhD, Koji.

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Hedi H Schreurs, Marianne J Wijers, Y

Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss Sophronia O Turner-Gomes, MB, ChB, Evan P Nitschmann,

Ricardo H Boks, BS, Lex A van Herwerden, MD, PhD, Johanna J

Increased intracerebral excitatory amino acids and nitric oxide after hypothermic circulatory arrest Elaine E Tseng, MD, Malcolm V Brock, MD, Christopher.

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Managing Fibrinolysis Without Aprotinin

Reversal of heparin anticoagulation by recombinant platelet factor 4 and protamine sulfate in baboons during cardiopulmonary bypass Alvise Bernabei,

Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction

Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Torsten Doenst, MD, Wolfgang Bothe, MD, Friedhelm Beyersdorf, MD

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial Domenico Paparella, MD, Crescenzia.

Hannu J Penttilä, MD, Martti V

Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements G.J. Despotis, MD, J.H. Joist,

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity Cedric Manlhiot, PhD, Colleen.

Support Your Specialty

Editorial Board, January 2010

Coronary endarterectomy with off-pump coronary artery bypass surgery

David L. Joyce, MD The Journal of Thoracic and Cardiovascular Surgery

Bradford B. Smith, MD, Matthew A

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Hypothermic Low-Flow Cardiopulmonary Bypass Impairs Pulmonary and Right Ventricular Function More Than Circulatory Arrest Jess M. Schultz, MD, Tara Karamlou,

Individualized heparin and protamine management in infants and children undergoing cardiac operations Massimiliano Codispoti, MD, Christopher A Ludlam,

The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations Kojiro Furukawa, MDa, Hitoshi Ohteki, MDa, Kenji Hirahara,

Safety and efficacy of a heparin removal device: a prospective randomized preclinical outcomes study Joseph B Zwischenberger, MD, Weike Tao, MD, Donald.

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary.

Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass Nobuhiko Hayashida, MD, PhD, Hiroshi Tomoeda, MD, Takeshi Oda, MD,

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J

Inflammatory Mediators in Adults Undergoing Cardiopulmonary Bypass: Comparison of Centrifugal and Roller Pumps Saeed Ashraf, John Butler, Yi Tian, Dahlia.

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Jeffrey M.

Delayed impairment of cerebral oxygenation after deep hypothermic circulatory arrest in children Eero J Pesonen, MD, Kaija I Peltola, MD, Reijo E Korpela,

Michael W. A. Chu, MD, Steve R. Wilson, BS, Richard J

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell,

Tachyarrhythmias and triggering factors for atrial fibrillation after coronary artery bypass operations Lena Jidéus, MD, Per Blomström, MD, PhD, Leif.

Preoperative Intraaortic Balloon Pump Enhances Cardiac Performance and Improves the Outcome of Redo CABG Jan T. Christenson, MD, PhD, Pierre Badel, MD,

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Fraser D. Rubens, MD, MS, Gilbert Lavalee, Marc A

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Serum S100β release after coronary artery bypass grafting: roller versus centrifugal pump Saeed Ashraf, Kausik Bhattacharya, Sunny Zacharias, Pradeep.

Comparison of Blood Activation in the Wound, Active Vent, and Cardiopulmonary Bypass Circuit Olivier Fabre, MD, PhD, André Vincentelli, MD, PhD, Delphine.

Advances in the heart-lung machine after John and Mary Gibbon

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury Christine S Rinder, MD, Manuel Fontes, MD,

Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations Wulf Dietrich, Karl Schöpf, Michael Spannagl, Marianne.

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Thrombophilic Variables Do Not Increase the Generation or Procoagulant Activity of Thrombin During Cardiopulmonary Bypass Peter Raivio, MD, Jari Petäjä,

Hemostasis Alterations in Patients With Acute Aortic Dissection

Presentation transcript:

Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD The Annals of Thoracic Surgery Volume 63, Issue 2, Pages 438-444 (February 1997) DOI: 10.1016/S0003-4975(96)01099-5

Fig. 1 Activated clotting times (ACT) and heparin (hep) anti-Xa activity (Anti-Xa) before (preop), during (CPB), and after (prot) cardiopulmonary bypass. (∗ = p < 0.05; ∗∗∗ = p < 0.001 between the groups.) The Annals of Thoracic Surgery 1997 63, 438-444DOI: (10.1016/S0003-4975(96)01099-5)

Fig. 2 Plasma concentrations of fibrinopeptide A (FPA), D-dimer (D-D), and prothrombin fragment (F 1 + 2) preoperatively and 10 minutes and 2 hours after protamine administration in the uncoated (white bars) and coated (black bars) groups. (CPB = cardiopulmonary bypass; ∗∗ = p < 0.01, ∗∗∗ = p < 0.001 between the groups.) The Annals of Thoracic Surgery 1997 63, 438-444DOI: (10.1016/S0003-4975(96)01099-5)